Who
Elizabeth Stoner
Director
Company insider
Files Form 4 as: Director, iBio; Director, Momenta Pharmaceuticals; Director, Radius Health; Director, Metabasis Therapeutics.
In numbers
- Trades disclosed
- 91
- Buys
- 0
- Sells
- 21
- Bought
- $0
- Sold
- $1.4M
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 14 Dec 2007
- Last trade
- 14 Oct 2026
- Last filed
- 15 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month. 1 lines have no legible date and are left out.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Oct 2026filed 15 Oct 2026 | IBIO iBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —38,000 at $0.00 | filing |
| 18 May 2026filed 19 May 2026 | IBIO iBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 18 May 2026filed 19 May 2026 | IBIO iBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 1 Oct 2020filed 1 Oct 2020 | Momenta Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —17,750 | filing |
| 1 Oct 2020filed 1 Oct 2020 | Momenta Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —17,750 | filing |
| 1 Oct 2020filed 1 Oct 2020 | Momenta Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —17,750 | filing |
| 1 Oct 2020filed 1 Oct 2020 | Momenta Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —17,750 | filing |
| 1 Oct 2020filed 1 Oct 2020 | Momenta Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —11,000 | filing |
| 1 Oct 2020filed 1 Oct 2020 | Momenta Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —11,207 | filing |
| 1 Oct 2020filed 1 Oct 2020 | Momenta Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —8,855 | filing |
| 1 Oct 2020filed 1 Oct 2020 | Momenta Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —25,000 | filing |
| 1 Oct 2020filed 1 Oct 2020 | Momenta Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —25,000 | filing |
| 1 Oct 2020filed 1 Oct 2020 | Momenta Pharmaceuticals | SEC FORM 4 Code D | —35,509 | filing |
| 23 Jun 2020filed 24 Jun 2020 | Momenta Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 14 Jan 2020filed 16 Jan 2020 | Momenta Pharmaceuticalsoption or derivative | SEC FORM 4 Code M | —5,750 at $0.00 | filing |
| 14 Jan 2020filed 16 Jan 2020 | Momenta Pharmaceuticals | SEC FORM 4 Code M | $76K5,750 at $13.16 | filing |
| 14 Jan 2020filed 16 Jan 2020 | Momenta Pharmaceuticals | SEC FORM 4 Sold | $106K4,236 at $25.00 | filing |
| 20 Jun 2019filed 21 Jun 2019 | Momenta Pharmaceuticalsoption or derivative | SEC FORM 4 Code M | —4,356 at $0.00 | filing |
| 20 Jun 2019filed 21 Jun 2019 | Momenta Pharmaceuticals | SEC FORM 4 Code M | —4,356 at $0.00 | filing |
| 19 Jun 2019filed 21 Jun 2019 | Momenta Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.